Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib)

Autor: Elmorsy, Elsayed A., Saber, Sameh, Hamad, Rabab S., Abdel-Reheim, Mustafa Ahmed, Nadwa, Eman Hassan, Alibrahim, Alaa Oqalaa E., Alkhamiss, Abdullah S., AlSalloom, A.A., Mohamed, Enas A., Nour-El-Din, M., Amer, Maha M., Abdel-Hamed, Mohamed R., Mohamed, Nahla B., Abozaid, Lobaina, Mostafa-Hedeab, Gomaa, Ahmed, Syed Suhail, Taha, Hagir Hussein, Khalifa, Amira Karam
Zdroj: In Life Sciences 1 October 2024 354
Databáze: ScienceDirect
Externí odkaz: